Scientific Report 2010 – 2011
Total Page:16
File Type:pdf, Size:1020Kb
Aichi Cancer Center Research Institute Scientific Report 2010 – 2011 Chikusa-ku, Nagoya 464-8681 Japan (The Cover) Looking at the Aichi Cancer Center Research Institute Main Building over the drooping cherries in bloom. Published by Dr. Kazuo Tajima Director Aichi Cancer Center Research Institute 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan Telephone: 052-762-6111 Facsimile: 052-763-5233 Editorial Committee Dr. Tatsuya Tsurumi (Division of Virology) Dr. Takayuki Murata (Division of Virology) Dr. Hiroshi Kumimoto (Division of Central Laboratory & Radiation Biology) Dr. Malcolm A. Moore, English Editor Ms. Hiromi Tamaki (Director's Office) Printed by Nagoya University COOP 1 Furoucho, Chikusa-ku, Nagoya 464-0814, Japan Contents Preface Kazuo Tajima 1 Organization of the Aichi Cancer Center Research Institute 2 SCIENTIFIC REPORTS Division of Epidemiology and Prevention General summary 5 1. Population-based Cancer Survival in Selected Registries in East Asia Ito, H., Matsuo, K., Tanaka, Hid., and Study group for Cancer Epidemiology and Statistics in East Asia. 6 2. The Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) Study Matsuo, K., Ito, H., Hosono, S., Kawase, T., Oze, I., Kawakita, D., Nakao, M., Hirose, K., Suzuki T., Chihara, D., Sueta, A., Sato, F., Islam, T., Sawamura, M., Yatabe, Y., Nakanishi T., Hasegawa, Y., Shinoda, M., Mitsudomi, T., Yamao, K., Iwata, H., Morishima Y., Hida, T., Seto, M., Murakami, S., Iida, S., Sato, S., Ueda, R., Nakamura, S., Iwase H., Tajima, K., and Tanaka, Hid. 7 2.1. Association between a GWAS-identified loci and risk of lung cancer in Japanese Ito, H., McKay, JD., Hosono, S., Hida, T., Yatabe, Y., Mitsudomi, T., Brennan, P., Tanaka, Hid., and Matsuo, K. 7 2.2. Weight gain during adulthood and body weight at age 20 are associated with the risk of endometrial cancer in Japanese women Hosono, S., Matsuo, K., Hirose, K., Ito, H., Suzuki T., Kawase, T., Watanabe, M., Nakanishi T., Tajima, K., and Tanaka, Hid. 8 2.3. Self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism as risk factors for upper aerodigestive tract cancer in a Japanese population Oze, I., Matsuo, K., Hosono, S., Ito, H., Kawase, T., Watanabe, M., Suzuki, T., Hatooka, S., Yatabe, Y., Hasegawa, Y., Shinoda, M., Tajima, K., and Tanaka, Hid. 8 2.4. Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma Kawakita, D., Matsuo, K., Sato, F., Oze, I., Hosono, S., Ito, H., Watanabe, M., Yatabe, Y., Hanai, N., Hasegawa, Y., Tajima, K., Murakami, S., and Tanaka, Hid. 9 2.5. ABO blood group alleles and the risk of pancreatic cancer in Japanese Nakao, M., Matsuo, K., Hosono, S., Ogata, S., Ito, H., Watanabe, M., Mizuno, N., Iida, S., Sato, S., Yatabe Y., Yamao, K., Ueda, R., Tajima, K., and Tanaka, Hid. 10 2.6. Inverse association between soy intake and non-Hodgkin lymphoma risk: a case-control study in Japan Chihara, D., Matsuo, K., Kanda, J., Hosono, S., Ito, H., Nakamura, S., Seto, M., Morishima Y., Tajima, K., and Tanaka, Hid. 10 2.7. Genetic risk prediction for breast cancer using a combination of low- i penetrance polymorphisms in a Japanese population Sueta, A., Ito, H., Kawase, T., Hirose, K., Hosono, S., Yatabe, Y., Tajima, K., Tanaka, Hid., Iwata, H., Iwase H., and Matsuo, K. 11 Division of Oncological Pathology General summary 14 1. Molecular delivery systems using novel cell-penetrating peptides (CPPs) for anti-cancer medicine Saito, K., Matsushita, M.,and Kondo, E. 15 2. Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins Inoue, T., Tashiro, Y., Takeuchi, M., Otani, T., Tsuji-Takayama, K., Okochi, A., Mukae, Y., Koreishi, M., Yamasaki, F., Kumon, H., Nakamura, S., Kibata, M. and Kondo, E. 16 3. miR-155, a modulator of FOXO3a protein expression, is underexpressed and is not upregulated by stimulation with HOZOT, a multifunctional Treg line Yamamoto, M., Kondo, E., Takeuchi, M., Harashima, A., Otani, T., Tsuji-Takayama, K., Yamasaki, F., Kumon, H., Kibata, M., and Nakamura, S. 17 4. Acquisition of an EMT phenotype by gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signaling Maseki, S., Ijichi, K., Tanaka, Ha., Fujii, M., Hasegawa, Y., Murakami. S, Kondo, E., and Nakanishi, H. 17 5. New multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with near-infraredfluorophore-labeled antibody and MRI in mice Tsuchida, D., Matsushima, S., Ogasawara, M., Ito, A., Misawa, K., Ito, Y., Kondo, E., Kaneda , N., and Nakanishi, H. 17 Division of Molecular Oncology General summary 20 1. LATS2 is a tumor suppressor gene for malignant mesothelioma Murakami, H., Mizuno, T., Taniguchi, T., Fujii, M., Ishiguro, F., Fukui, T., Akatsuka, S., Horio, Y., Hida, T., Kondo, Y., Toyokuni, S., Osada, H., and Sekido, Y. 21 2. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer Nishikawa, E., Osada, H., Okazaki Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi A., Shimada, Y., Yanagisawa, Y., Yatabe, Y., Toyokuni, S., Sekido, Y., and Takahashi, Ta. 21 3. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumor Okamoto, Y., Sawaki, A., Ito, S., Nishida, T., Takahashi, T., Toyota, M., Suzuki, H., Shinomura, Y., Takeuchi, I., Shinjo, K., An, B., Ito, H., Yamao, K., Fujii, M., Murakami, H., Osada, H., Kataoka, H., Joh ,T., Sekido, Y., and Kondo, Y. 22 ii Division of Molecular Medicine General summary 25 1. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses Karube, K., Nakagawa, M., Tsuzuki, S., Takeuchi, I., Honma, K., Nakashima, Y., Shimizu, N., Ko, Y.H., Morishima, Y., Oshima, K., Nakamura, S., and Seto, M. 25 2. Synergistic effects of Bcl2, Myc and Ccnd1 in transforming mouse primary B cells into malignant cells Nakagawa, M., Honma, K., Tsuzuki, S., and Seto, M. 26 3. Establishment of an in vitro assay system allowing functional analysis of oncogenes in mature B cells Honma, K., and Seto, M. 26 4. Clonal evolution of adult T-cell leukemia/lymphoma takes place in lymph nodes Umino, A., Nakagawa, M., Utsunomiya, A., Tsukasaki, K., Taira, N., Katayama, N., and Seto, M. 27 5. Promotion and maintenance of leukemia by ERG Tsuzuki, S., and Seto, M. 27 6. Expansion of functionally defined mouse hematopoietic stem and progenitor cells by a short isoform of RUNX1/AML1 Tsuzuki, S., and Seto, M. 27 Division of Immunology General summary 29 1. Induction of cancer-specific CTL using artificial antigen presenting cells expressing an extrinsic HLA of interest while silencing intrinsic counterparts Demachi-Okamura, A., Kondo, S., Nishizawa, M., Yamamoto, E., Shibata, K., Kikkawa, F., and Kuzushima, K. 30 2. Zoledronate sensitizes ‘tumor-initiating cells’ from neuroblastoma lines to lysis by human gammadelta T cells Nishio, No., Tanaka, Y., Zhang, R., Hirosawa, T., Demachi-Okamura, A., Uemura, Y., Fujita, M., Taguchi, O., Takahashi, Y., Kojima, S., and Kuzushima, K. 30 3. Development of a novel adoptive immunotherapy using invariant natural killer T cells expressing a tumor-reactive T cell receptor Uemura, Y., Mineno, J., Ikeda, H., Shiku, H., and Kuzushima, K. 30 4. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation Hirosawa, T., Torikai, H., Yanagisawa, M., Kamei, M., Imahashi, N., Demachi-Okamura, A., Tanimoto, M., Shiraishi, K., Ito M., Miyamura, K., Shibata, K., Kikkawa, F., Morishima, Y., Takahashi, To., Emi, N., Kuzushima, K., and Akatsuka, Y. 31 5. Identification of minor histocompatibility antigens responsible for pulmonary graft-versus-host disease following adoptive immunotherapy Akatsuka, Y., Warren, E.H., Fujii, N., Brown, M.L., Ogawa, S., Matsubara, A., and Riddell, S.R. 32 6. Role of type 1 IFNs in antiglioma immunosurveillance - using mouse iii studies to guide examination of novel prognostic markers in humans Fujita, M., Scheurer, M.E., Decker, S.A., McDonald, H.A., Kohanbash, G., Kastenhuber, E.R., Kato, H., Bondy, M.L., Ohlfest, J.R., and Okada, H. 32 7. COX-2 blockade suppresses gliomagenesis by inhibiting accumulation of myeloid-derived suppressor cells Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R.L., Komohara, Y., Decker, S.A., Ohlfest, J.R., and Okada, H. 33 Division of Virology General summary 36 1. Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1 Noda, C., Murata, T., Kanda, T. and Tsurumi, T 36 2. Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency Murata, T. and Tsurumi, T. 37 3. Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with histone deacetylase association Murata, T. and Tsurumi, T. 37 4. Tetrameric ring formation of Epstein-Barr virus polymerase processivity factor is crucial for viral replication Nakayama, S. and Tsurumi, T. 38 5. Spatiotemporally different DNA repair systems participate in Epstein-Barr virus genome maturation Sugimoto, A. and Tsurumi, T. 38 6. Unexpected instability of Family of Repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems Kanda, T. and Tsurumi, T. 39 7. Human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication Isomura, H. and Tsurumi, T. 40 Division of Molecular Pathology General summary 42 1. Induction of selectin-ligand glycans during the epithelial-mesenchymal transition of colon cancer Sakuma, K., Aoki, M. and Kannagi, R. 42 2. Induction of sialyl Lewis x by epigenetic silencing of DTDST expression Yusa, A., Miyazaki, K., Lim, K.T., Yin, J., Yagi, H.